JHL Biotech
Mr. Fong has more than 23 years of experience in biotechnology and investment management. He is currently a founding General and Managing Partner of Biomark Capital, a $200+ million life science fund, established in 2013. Prior to forming Biomark Capital, he was with Burrill Capital Management managing life science funds with committed capital of over $1 billion. Mr. Fong has played a lead role in over 25 private and public life science financings and currently serves on the boards of directors of a number of private life science companies. Mr. Fong earned his B.A. with honors in Molecular and Cell Biology-Biochemistry from the University of California, Berkeley.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
JHL Biotech
Eden Biologics is a biopharmaceutical company that develops biosimilars and accelerates the development programs for clients & partners.